Intermediate-dose cytarabine or standard-dose cytarabine plus single-dose anthracycline as post-remission therapy in older patients with acute myeloid leukemia: impact on health care resource consumption and outcomes - Jean Galtier; Camille Alric; Emilie Bérard; Thibaut Leguay; Suzanne Tavitian; Audrey Bidet; Eric Delabesse; Jean Baptiste Rieu; Jean-Philippe Vial; François Vergez; Nicolas Lechevalier; Isabelle Luquet; et al. (Blood Cancer Journal, 2021)